Wockhardt Ltd

Type: Company
Name: Wockhardt Ltd
Nationality: India
Fact Sheet: Fact Sheet for Wockhardt Ltd.
First reported 22 hours ago - Updated 6 hours ago - 1 reports

Nifty surges past 8,000 as markets hit all-time high again

All the sectoral indices were trading higher. The BSE consumer durable index was the top sectoral gainer, up 1.1%. Photo: Hemant Mishra/MintMumbai: Benchmark equity indices — Sensex and Nifty — touched a record high on Monday morning, on better than expected ... [Published Livemint.com - 22 hours ago]
First reported 12 hours ago - Updated 7 hours ago - 2 reports

Wockhardt gets QIPD status for anti-infectives

Drugmaker Wockhardt’s plans towards new drug discovery in the anti-infective segment, received a booster shot from the US drug regulator as two of its drugs fetched a qualified infectious disease product (QIPD) status, making way for an earlier launc ... [Published Financial Chronicle - 7 hours ago]
First reported Aug 31 2014 - Updated 15 hours ago - 24 reports

Wockhardt shares gain nearly 3% on bourses

Shares of drug maker Wockhardt today rose by nearly 3 per cent as two of its anti-infective drugs have received Qualified Infectious Disease Product (QIDP) status from the US health regulator.The drug maker's scrip ended 2.78 per cent higher at Rs 709.70 ... [Published Business Standard India - 15 hours ago]
First reported Sep 01 2014 - Updated 18 hours ago - 2 reports

Wockhardt Again Recalls Blood Pressure Drug In U.S.

Article # 28140901006Posted: Sep. 1, 2014 6:50 AM GMTExecutive SummaryFor the third time in four months, Wockhardt has recalled its metoprolol generic of AstraZeneca 's Toprol for treating high blood pressure, again for failing dissolution tests. ... [Published Health News Daily - 18 hours ago]
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Top buzzing stocks to trade on September 1

Here are few top buzzing stocks picked by CNBC-TV18's analysts in trade today. We have Hindalco, JSPL, Maruti Suzuki, Eicher Motors, Hero MotoCorp, IRB Infrastructure, Wockhardt, Sun TV, Mafatlal Industries, Elecon Engineering and ADF Foods. ... [Published Moneycontrol.com - 19 hours ago]
First reported Sep 01 2014 - Updated 21 hours ago - 1 reports

Pharma co shares in limelight with better Q1 performance

The Bombay Stock Exchange healthcare index of 17 leading pharmaceutical companies has outperformed BSE Sensex of 30 companies during August 2014. BSE healthcare index improved sharply by 8.2 per cent and closed at 13356.87 as compared to12341.28 as at ... [Published PharmaBiz - Sep 01 2014]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

RIL, ONGC and Wockhardt to see some action today

Reliance Industries (RIL) has returned nearly 1,384 acres of land in Gurgaon that was acquired for its SEZ, saying that the withdrawal of the concessions offered to special economic zones (SEZ) has made such projects unviable. Reliance Haryana SEZ (RHSL) ... [Published Indian-Commodity - 21 hours ago]
First reported 22 hours ago - Updated 22 hours ago - 1 reports

Here are top 10 stocks to keep an eye on Sep 1

- Sun TV, Spicejet, JSPL, Hindalco, Coal India, Cipla, Wockhardt, Natco Pharma, Bharti Airtel and Bajaj Electricals. ... [Published Moneycontrol.com - 22 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

HCL Technologies, Maruti Suzuki, Wockhardt in Focus Today

The Nifty is likely to open higher on Monday as indicated by futures trade on Singapore Stock Exchange. Foreign investors had sold stocks worth Rs 711 crore in cash market on last Thursday. However domestic investors remained net buyers, as they bought ... [Published NDTV Profit - 23 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Markets likely to open firm; 5 stocks to be in focus

Markets are likely to see a positive opening today following increase in the country's growth rate in June quarter which was announced on Friday.Besides cautious sentiment may prevail as the Supreme Court will decide the fate of coal blocks and announcement ... [Published Business Standard India - 23 hours ago]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Wockhardt Q1 profit decreases

Wockhardt Limited, a pharmaceutical and biotechnology company, has reported a profit after tax of INR200 million, or INR1.8 per share, for the first quarter ended June 30, 2014, compared to INR3.24 billion, or INR29.6 per share, for the same quarter ended ... [Published Individual.com - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 2 reports

Is Lupin lining up a bid for Wockhardt?

Lupin's managing director says there are some synergies and a lot of duplication between the two companiesRs 7,855.09 crore – Wockhardt's market capRs 56,645.49 crore-- Lupin's market capPharma major Lupin, which has been scouting for companies in the ... [Published DNA India - Aug 26 2014]

Quotes

Commenting on the development, Wockhardt Founder Chairman and GroupGroup CEO Dr Habil Khorakiwala had said, "This is indeed a proud moment for us. Not only does the status allow for fast track review of our drug application, it also grants a five- year extension to the drug patents in the USA, which is a major support for the commercial aspect of the drug."
In this regard, Dr Habil Khorakiwala, founder & chairman, said "Globally there is a significant antibiotic vacuum due to dual impact of rise in new resistant pathogens and declining research in this area which causes over 50,000 deaths in USA and Europe combined despite having excellent healthcare services.  The emerging world may as well be sitting on an antibiotic time-bomb ready to explode.  Superficially the bacterial diseases can be divided in two categories, gram positive and gram negative and these pathogens have prevalence in both of them.  Over the years Wockhardt has developed a strong anti-infective programme which focuses on development of drugs which target this antibiotic gap in both gram positive and gram negative domains."
"These drugs will be entering their global Phase-3 clinical trials early next year" Habil Khorakiwala, Wockhardt group CEO (Chief Executive Officer) and founder chairman, told Mint
Wockhardt Ltd has informed BSE regarding a Press Release dated August 31, 2014 titled "WCK 771 and WCK 2349, the two anti infective drugs from Wockhardt, get QIDP status" . Wockhardt's New Drug Discovery Programme in Anti-Infective research received a major boost after two of its drugs, WCK 771 and WCK 2349, received the...

More Content

All (238) | News (224) | Reports (0) | Blogs (11) | Audio/Video (0) | Fact Sheets (3) | Press Releases (0)
sort by: Date | Relevance
Wockhardt gets QIPD status for anti-infectives [Published Financial Chronicle - 7 hours ago]
Will take 2-2.5 yrs for phase-3 clinical trails... [Published Moneycontrol.com - 12 hours ago]
Wockhardt shares gain nearly 3% on bourses [Published Business Standard India - 15 hours ago]
Sensex ends 230 points up at new high; Nifty cl... [Published Sify - 15 hours ago]
Wockhardt Ltd soars after receiving QIDP status... [Published TopNews United States - 15 hours ago]
Wockhardt's two anti infective drugs get QIDP s... [Published PharmaBiz - 15 hours ago]
Danone All Set To Enter Indian Market [Published Scoop Asia - 17 hours ago]
FDA grants QIDP status for Wockhardt anti-infec... [Published PBR - News - 17 hours ago]
Wockhardt gains after USFDA agrees to fast trac... [Published Hindu Business Line - 17 hours ago]
Wockhardt's Drugs get USFDA Approval, Stocks Soar [Published International Business Times India - 18 hours ago]
Wockhardt Again Recalls Blood Pressure Drug In ... [Published Health News Daily - 18 hours ago]
Wockhardt’s infective drugs receive QIDP status... [Published Express Pharma - 19 hours ago]
Wockhardt gains as USFDA grants QIDP status to ... [Published Business Standard India - 19 hours ago]
Top buzzing stocks to trade on September 1 [Published Moneycontrol.com - 19 hours ago]
Wockhardt bags QIDP approval for two anti-infec... [Published Business Standard India - 19 hours ago]
Wockhardt's drug discovery gets a boost with fa... [Published Moneycontrol.com - 20 hours ago]
US regulator fast-tracks approval for Wockhardt... [Published Rediff Realtime News - 20 hours ago]
USFDA grants QIDP status for Wockhardt drugs [Published MyIris - 21 hours ago]
Wockhardt soars on getting QIDP status for two ... [Published Arihant Capital - 21 hours ago]
RIL, ONGC and Wockhardt to see some action today [Published Indian-Commodity - 21 hours ago]
Nifty surges past 8,000 as markets hit all-time... [Published Livemint.com - 22 hours ago]
Wockhardt Surges 6% on New Drug Approval [Published NDTV Profit - 22 hours ago]
Wockhardt drug discovery fast track nod by USFDA [Published Press Trust of India - 22 hours ago]
Wockhardt rallies 6% on receiving QIDP status [Published Economic Times - 22 hours ago]
Wockhardt gains 5% post USFDA fast-tracks nod f... [Published Business Standard India - 22 hours ago]
Here are top 10 stocks to keep an eye on Sep 1 [Published Moneycontrol.com - 22 hours ago]
U.S. FDA Grants QIDP Status for Wockhardt Anti-... [Published Bio-Medicine - 23 hours ago]
HCL Technologies, Maruti Suzuki, Wockhardt in F... [Published NDTV Profit - 23 hours ago]
Markets likely to open firm; 5 stocks to be in ... [Published Business Standard India - 23 hours ago]
Pharma co shares in limelight with better Q1 pe... [Published PharmaBiz - Sep 01 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
FDA grants QIDP status for Wockhardt anti-infec... [Published PBR - News - 17 hours ago]
Wockhardt Limited has announced a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product (QIDP) status from U.S. Food & Drug Administration ...
U.S. FDA Grants QIDP Status for Wockhardt Anti-... [Published PR Newswire: Health - Sep 01 2014]
PARSIPPANY, N.J., Aug. 31, 2014 /PRNewswire/ -- Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease ...
CEFTRIAXONE Injection, Powder, For Solution CEF... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Updated Date: Aug 19, 2014 EST ...
BDA Named M&A Advisor of the Year at the 2014 A... [Published PR.com Press Releases - Jun 21 2014]
New York, NY, June 21, 2014 --( PR.com )-- Business Development Asia LLC (“BDA”) was named M&A Advisor of the Year at the ACG Champion’s Awards, held on June 19th in New York. ACG New York is the leading association for middle market dealmaking professionals: ...
What Did the FDA Find at the Wockhardt Plant? L... [Published WSJ.com: India Real Time - Jun 04 2014]
A recent FDA inspection of a key U.S. plant run by Wockhardt, an Indian drug maker that is a large supplier to the U.S., found a dozen quality-control problems and is likely to further underscore regulatory concerns about the Indian pharmaceutical industry's ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.